Blog
RSS FeedPosted by Michael Wonder on 05 Mar 2020
Online pharmacy Ro is testing a program that sends you generic prescriptions for $5 per month without insurance
5 March 2020 - The company started out with a focus on men’s health, initially with prescription erectile dysfunction and hair ...
Posted by Michael Wonder on 04 Mar 2020
World's main supplier of generic drugs could run out of ingredients
4 March 2020 - India, the world's main supplier of generic drugs, has restricted the export of 26 pharmaceutical ingredients ...
Posted by Michael Wonder on 29 Feb 2020
FDA approves first generic of Daraprim
28 February 2020 - Agency continues to support competition in generic drugs, increasing patient access to more affordable medicines. ...
Posted by Michael Wonder on 25 Feb 2020
Perrigo and Catalent announce FDA approval of Perrigo's AB-rated generic version of ProAir HFA
24 February 2020 - Perrigo and its partner, Catalent Pharma Solutions, today announced that the U.S. FDA has approved Perrigo's abbreviated ...
Posted by Michael Wonder on 25 Feb 2020
FDA approves first generic of ProAir HFA
24 February 2020 - Agency supports development of complex generic drugs to improve competition and access to more affordable medicines. ...
Posted by Michael Wonder on 24 Feb 2020
Teva announces FDA approval of ArmonAir Digihaler (fluticasone propionate) inhalation powder
24 February 2020 - Teva’s digital inhaler portfolio now includes products from three of the most commonly prescribed classes of ...
Posted by Michael Wonder on 20 Feb 2020
Serving public health paramount in a successful 2019 for FDA’s generic drug program
19 February 2020 - Safe, effective, high-quality generic drugs play a vital role in the U.S. health care system. ...
Posted by Michael Wonder on 19 Feb 2020
FDA touts generic drug research in 2019
19 February 2020 - The US FDA on Tuesday released a report detailing the scientific research carried out and funded ...
Posted by Michael Wonder on 30 Jan 2020
FDA updates prioritization policy for original abbreviated new drug applications, amendments and supplements to maximise impact on public health
30 January 2020 - Today, the U.S. FDA is making critical updates to our policy for prioritising the review of ...
Posted by Michael Wonder on 25 Jan 2020
Bipolar disorder patients suffer 'terrible' side effects after PHARMAC drug brand switch
25 January 2020 - A woman with bipolar disorder says she was "crying everyday" and having thoughts of suicide after ...
Posted by Michael Wonder on 16 Jan 2020
Epilepsy deaths: level of risk in medication brand switch unclear, study says
17 January 2020 - Five deaths in people with epilepsy following a brand switch may be part of an under-represented level ...
Posted by Michael Wonder on 16 Jan 2020
U.S. targets drug pricing, no-poach deals for anti-trust action in 2020
15 January 2020 - Justice Department antitrust chief also promises decision on music licensing, criticizes states’ lawsuit against T-Mobile and Sprint. ...
Posted by Michael Wonder on 09 Jan 2020
California eyes selling its own brand of generic prescription drugs to battle high costs
9 January 2020 - California would become the first state to sell its own brand of generic prescription drugs in ...
Posted by Michael Wonder on 09 Jan 2020
PHARMAC epilepsy drug process questions
10 January 2020 - There are many unanswered questions about PHARMAC's decision to fund only one brand of the epilepsy ...
Posted by Michael Wonder on 06 Jan 2020
Generic makers will appeal ruling that allows California to proceed with law banning pay-to-delay deals
3 January 2020 - A federal judge dealt the pharmaceutical industry a setback by declining to block a new California ...